ArticleCPT: pharmacometrics & systems pharmacology2025

Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events.

Ashraf Yassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.